CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Predicting resistance to platinum-containing chemotherapy with the ATP tumorchemosensitivity assay in primary ovarian cancer
DOI 10.1055/s-0028-1088846
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Neubauer, M Stefanova, C Meisner, D Wallwiener, E Solomayer, T Fehm
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Most patients with primary epithelial ovarian cancer (PEOC) treated with carboplatin/paclitaxel will relapse between one to two years. Our purpose was to define the optimal calculation method for the ATP Tumor Chemosensitivity assay (ATP-TCA) applied to PEOC treated with platinum-containing chemotherapy and to analyze its predictive relevance. Material and Methods: ATP-TCA results from 80 PEOC specimens were a…
Zitieren
Zitierempfehlung
H Neubauer, M Stefanova, C Meisner, D Wallwiener, E Solomayer, T Fehm (2008) Predicting resistance to platinum-containing chemotherapy with the ATP tumorchemosensitivity assay in primary ovarian cancer. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-0028-1088846
Mit CareLit weiterarbeiten